Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ProShares Ultra Silver ETF (AGQ) vs BridgeBio Pharma Inc (BBIO) Price & Performance

ProShares Ultra Silver ETFTrade
BridgeBio Pharma IncTrade

Price performance (Past 24H)

Key statistics

ProShares Ultra Silver ETF vs BridgeBio Pharma Inc — how do they compare? ProShares Ultra Silver ETF trades at $83, while BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B). The key difference: BridgeBio Pharma Inc is trading nearer its 52-week high, ProShares Ultra Silver ETF nearer its low. Which is the better fit depends on your goals.

AGQBBIO
Sector
Leveraged / InverseHealth
52-Week High
$400.47$90.17
52-Week Low
$49.73$47.29
Market Cap
$16.36B
Enterprise Value
$18.14B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ProShares Ultra Silver ETF

AGQ is a leveraged ETF that seeks daily investment results corresponding to two times (2x) the daily performance of silver bullion. It is designed for investors seeking magnified short-term exposure to silver prices.

Read more on AGQ

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO